SEC Form 4 · accession 0001593968-19-000395
Vericel Corp · VCEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gerard J Michel
Officer — CFO and VP, Corp. Development
Period of report
Feb 6, 2019
Accepted (ET)
Feb 8, 2019 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000887359
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $16.66 | Feb 6, 2019 | A | 9,303 | A | May 6, 2019 | Feb 6, 2029 | Common Stock | 9,303 | 9,303 | D |
| Stock Option (right to buy)F1 | $16.66 | Feb 6, 2019 | A | 113,197 | A | May 6, 2019 | Feb 6, 2029 | Common Stock | 113,197 | 113,197 | D |
| Restricted Stock UnitF2,F3,F4 | — | Feb 6, 2019 | A | 12,000 | A | — | — | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1These options shall begin vesting on February 6, 2019 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.
- F2Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
- F3These RSUs vest in four annual installments with 3,000 RSUs vesting on February 6, 2020, February 6, 2021, February 6, 2022, and February 6, 2023, respectively.
- F4No expiration date for this type of award.